Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Initial study to evaluate local control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor removal.

Trial Details

NCT ID

NCT02843945

Phase

PHASE1 / PHASE2

Sponsor

CivaTech Oncology

Status

RECRUITING

Cancer Type

Pancreatic Cancer

Interventions

Directional Brachytherapy Source Implant

Locations (sample)

Tampa, Florida, United States|27.94752,-82.45843
Chicago, Illinois, United States|41.85003,-87.65005
Oak Lawn, Illinois, United States|41.71087,-87.75811
New Orleans, Louisiana, United States|29.95465,-90.07507
Philadelphia, Pennsylvania, United States|39.95238,-75.16362

Key Eligibility Criteria

• Subject signed inform consent
Age \> 18 years
Not pregnant or breast feeding
Patient capable of undergoing anesthesia

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →